Asia Pacific Transcriptomics Market

Asia Pacific Transcriptomics Market Size, Share & Industry Trends Analysis Report By Technology (q PCR, Microarrays, and Sequencing Technology), By Application, By Component, By Country and Growth Forecast, 2021 - 2027

Report Id: KBV-8533 Publication Date: April-2022 Number of Pages: 102
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support

Analysis of Market Size & Trends

The Asia Pacific Transcriptomics Market would witness market growth of 8.3% CAGR during the forecast period (2021-2027).

Transcriptomics is the exploration of the transcriptome, which is the entire set of RNA transcripts produced by the genome under certain conditions or in a specific cell, utilizing high-throughput technologies like microarray analysis. In addition, genes that are differentially expressed in different cell groups or in response to different treatments can be identified by comparing transcriptomes.

Rising R&D spending in transcriptomic technologies by pharmaceutical and biotechnology companies, as well as increased demand for tailored medication in cancer treatment, are driving the growth of the RNA analysis/transcriptomics market. Additionally, Oxford Brookes University recognized the development of improved single-cell transcriptomic technologies in April 2021. These technologies evaluate several individual cells from living creatures and sequence each cell's genetic material. According to the study, this procedure allows scientists to swap samples between labs, maintain the material, and freeze sample sets to examine at the same time without harming the cell's quality.

Governments and businesses are increasing their funding for biotechnology research in Asia Pacific countries. In addition, the Japanese government and non-government groups are enthusiastic about the advancement of biotechnology research in Japan, and they sponsor research in health and the life sciences. This pushes scientists to go deeper into the transcriptomics field. Furthermore, the increased focus on Asia Pacific nations is likely to give growth prospects for manufacturers due to low-cost manufacturing services. Moreover, the leading players of the regional market have shifted their attention to emerging markets and begun to build a robust position in the market through various strategic efforts, such as acquisitions.

The growing applications of Transcriptomics in Human and pathogen transcriptomes would boost its usage in the regional market. The majority of transcriptomic research has focused on either the host or the pathogen.

The China market dominated the Asia Pacific Transcriptomics Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $705.9 million by 2027. The Japan market is anticipated to grow at a CAGR of 7.7% during (2021 - 2027). Additionally, The India market would display a CAGR of 9% during (2021 - 2027).

Based on Technology, the market is segmented into q PCR, Microarrays, and Sequencing Technology. Based on Application, the market is segmented into Drug Discovery, Diagnostics & Disease Profiling, and Others. Based on Component, the market is segmented into Consumables, Instruments, Software, and Services. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

Free Valuable Insights: The Worldwide Transcriptomics Market is Projected to reach USD 9.4 Billion by 2027, at a CAGR of 7.6%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Fluidigm Corporation, Promega Corporation, General Electric (GE) Co., Merck & Co., Inc., Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., and Qiagen N.V.

Scope of the Study

Market Segments Covered in the Report:

By Technology

  • q PCR
  • Microarrays
  • Sequencing Technology

By Application

  • Drug Discovery
  • Diagnostics & Disease Profiling
  • Others

By Component

  • Consumables
  • Instruments
  • Software
  • Services

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

  • Fluidigm Corporation
  • Promega Corporation
  • General Electric (GE) Co.
  • Merck & Co., Inc.
  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Qiagen N.V.
Need a report that reflects how COVID-19 has impacted this market and its growth? Download Free Sample Now
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo